What this instrument does
The National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment (August Update) Instrument 2026 is a technical update to the federal rules that control how chemotherapy drugs are funded under the Pharmaceutical Benefits Scheme (PBS).
The instrument amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024, which sets out how pharmacies and hospitals are funded for supplying chemotherapy medicines. It amends the existing arrangement under the National Health Act 1953.
The source text provided does not specify the detailed changes made by this August update, only that it amends the existing arrangement.
Timing
The instrument was in force from 31 July 2026 to 12 October 2026 and has since been repealed.
Scope
This mainly concerns pharmacies, hospitals and health providers involved in dispensing chemotherapy drugs under PBS funding arrangements, rather than general small businesses.
Key actions
- If a pharmacy or health service is involved in chemotherapy drug supply, check with the relevant PBS systems provider or peak body to confirm which funding arrangements currently apply, since this instrument has already been repealed.
- Visit the Federal Register of Legislation page at https://www.legislation.gov.au/F2026L01019 to view the full legislative text and explanatory statement for specific details not covered in this summary.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.